First Report of Vancomycin-Intermediate Resistance in Sequence Type 72 Community Genotype Methicillin-Resistant Staphylococcus aureus

被引：11
|
作者：
Chung, Doo Ryeon [1 ,2 ]
Baek, Jin Yang [2 ]
Kim, Hyun Ah [1 ]
Lim, Min Hee [1 ]
Kim, So Hyun [2 ]
Ko, Kwan Soo [3 ]
Kang, Cheol-In [1 ]
Peck, Kyong Ran [1 ]
Lee, Nam Yong [4 ]
Song, Jae-Hoon [1 ,2 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis, Seoul, South Korea
[2] APFID, Seoul, South Korea
[3] Sungkyunkwan Univ, Dept Mol Cell Biol, Sch Med, Suwon, South Korea
[4] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med, Seoul, South Korea
来源：
JOURNAL OF CLINICAL MICROBIOLOGY | 2012年 / 50卷 / 07期
关键词：
UNITED-STATES; SUSCEPTIBILITY; INFECTIONS; HOSPITALS; STRAINS;
D O I：
10.1128/JCM.00590-12
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Vancomycin-intermediate resistance has not been previously reported among sequence type 72 (ST72) methicillin-resistant Staphylococcus aureus (MRSA) isolates of SCCmec type IV (ST72-MRSA-IV), which are distinctive community genotype strains in Korea. We report the first case of vancomycin treatment failure due to development of vancomycin-intermediate resistance in infection caused by an ST72-MRSA-IV isolate.
引用
收藏
页码：2513 / 2514
页数：2
相关论文
共 50 条
  • [21] The activity of vancomycin against heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus explored using an in vitro pharmacokinetic model
    Turner, J
    Howe, RA
    Wootton, M
    Bowker, KE
    Holt, HA
    Salisbury, V
    Bennett, PM
    Walsh, TR
    MacGowan, AP
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (05) : 727 - 730
  • [22] Evaluation of apramycin activity against methicillin-resistant, methicillin-sensitive, and vancomycin-intermediate Staphylococcus aureus clinical isolates
    Truelson, Katherine A.
    Brennan-Krohn, Thea
    Smith, Kenneth P.
    Kirby, James E.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 92 (02) : 168 - 171
  • [23] First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand
    Trakulsomboon, S
    Danchaivijitr, S
    Rongrungruang, Y
    Dhiraputra, C
    Susaemgrat, W
    Ito, T
    Hiramatsu, K
    JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (02) : 591 - 595
  • [24] Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model
    Zhanel, George G.
    Voth, Dylan
    Nichol, Kim
    Karlowsky, James A.
    Noreddin, Ayman M.
    Hoban, Daryl J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (02) : 364 - 369
  • [25] Emergence of Vancomycin-Intermediate Staphylococcus aureus from Predominant Methicillin-Resistant S. aureus Clones in a Korean Hospital
    Cha, Hwa Yun
    Kim, Hyun Ok
    Jin, Jong Sook
    Lee, Je Chul
    JOURNAL OF MICROBIOLOGY, 2010, 48 (04) : 533 - 535
  • [26] Emergence of vancomycin-intermediate Staphylococcus aureus from predominant methicillin-resistant S. aureus clones in a Korean hospital
    Hwa Yun Cha
    Hyun Ok Kim
    Jong Sook Jin
    Je Chul Lee
    The Journal of Microbiology, 2010, 48 : 533 - 535
  • [27] In Vitro Activity of Ceftaroline against Community-Associated Methicillin-Resistant, Vancomycin-Intermediate, Vancomycin-Resistant, and Daptomycin-Nonsusceptible Staphylococcus aureus Isolates
    Saravolatz, Louis
    Pawlak, Joan
    Johnson, Leonard
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (07) : 3027 - 3030
  • [28] The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus
    Appelbaum, PC
    CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 : 16 - 23
  • [29] Novel Combinations of Vancomycin plus Ceftaroline or Oxacillin against Methicillin-Resistant Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA
    Werth, B. J.
    Vidaillac, C.
    Murray, K. P.
    Newton, K. L.
    Sakoulas, G.
    Nonejuie, P.
    Pogliano, J.
    Rybak, M. J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (05) : 2376 - 2379
  • [30] Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus
    Chambers, HF
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (03) : 884 - 888
12345